Brazil halts single-dose dengue vaccine after deaths
The Brazilian government has temporarily suspended the use of the single-dose dengue vaccine developed by the Butantan Institute, after two deaths suspected to be linked to the vaccine were reported. The vaccine, which was approved by authorities in November, has been administered to over 500,000 people, mostly healthcare workers. The Minister of Health confirmed that there is currently no evidence of a direct link between the vaccine and the two cases, but the decision was made as a precautionary measure while investigations continue.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)